Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2026-09-15 21:30:04 ET · period of report 2026-09-11 · accession 0001193125-26-392319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 21:30 | 2026-09-11 | TENX | STAAB THOMAS R II | CFO | P - Purchase | $1.94 | +5,675 | 15.7K | +57% | +$11.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | P | A | 5,675 | $1.94 | 15,675 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.90 to $1.95. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |